Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-01-10 @ 8:59 PM
Study NCT ID:
NCT03291158
Status:
WITHDRAWN
Last Update Posted:
2023-09-21
First Post:
2017-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
Sponsor:
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2018-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-09-18
First Submit QC Date:
None
Study First Post Date:
2017-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-19
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL